- Lilly Employer Connect Adds Flexibility for Employers But Isn’t Revolutionary, Expert Says
by Marissa Plescia on March 5, 2026 at 11:33 pmEli Lilly’s new Lilly Employer Connect platform offers employers more flexible access to obesity drugs like Zepbound, but experts say it represents only incremental progress. The post Lilly Employer Connect Adds Flexibility for Employers But Isn’t Revolutionary, Expert Says appeared first on MedCity News.
- AI Startups Are Tying Fees to Completed Tasks. Will Hospitals Buy In?
by Katie Adams on March 5, 2026 at 10:06 pmHealthcare AI startups are experimenting with pricing models that tie their costs to real-world results, such as completed tasks or improved patient outcomes. While investors see this as a way to prove value, many hospitals remain skeptical, preferring predictable pricing. The post AI Startups Are Tying Fees to Completed Tasks. Will Hospitals Buy In? appeared first on MedCity News.
- Startup Atavistik Adds $40M for Clinical Trial in Rare Bleeding Disorder With No Approved Therapies
by Frank Vinluan on March 5, 2026 at 6:50 pmThe Series B extension brings Atavistik Bio’s Series B financing to $160 million. The startup’s lead program is in development for hereditary hemorrhagic telangiectasia (HHT), an inherited bleeding disorder. The post Startup Atavistik Adds $40M for Clinical Trial in Rare Bleeding Disorder With No Approved Therapies appeared first on MedCity News.
- How to Build Effective Referral Networks and Improve Patient Navigation [Video]
by wlim on March 5, 2026 at 5:15 pm[Sponsored] Healthcare executives spoke with MedCity News on how their businesses are using tech to shape the clinician and patient experience. The post How to Build Effective Referral Networks and Improve Patient Navigation [Video] appeared first on MedCity News.
- Why Hospital Outpatient Isn’t the Default for Long-Term Infusion Anymore
by Shane Reeves on March 5, 2026 at 3:02 pmThe move toward infusion centers as the preferred site of care is not a short-term response. It aligns with broader industry trends, including specialty drug pipelines that continue to favor infused biologics and a sustained rise in infusion demand. The post Why Hospital Outpatient Isn’t the Default for Long-Term Infusion Anymore appeared first on MedCity News.
